Cinclus Pharma Holding AB (publ) (STO:CINPHA)
Sweden · Delayed Price · Currency is SEK 17.18
-0.28 (-1.60%)
At close: Aug 1, 2025
Inozyme Pharma Market Cap
Cinclus Pharma Holding AB has a market cap or net worth of 799.52 million as of August 1, 2025. Its market cap has decreased by -49.02% in one year.
Market Cap
799.52M
Enterprise Value
276.00M
Revenue
4.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$17.18
Market Cap Chart
Since June 20, 2024, Cinclus Pharma Holding AB's market cap has decreased from 1.52B to 799.52M, a decrease of -47.31%. That is a compound annual growth rate of -43.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 799.52M | -19.64% |
| Dec 30, 2024 | 994.98M | -34.43% |
| Jun 20, 2024 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.35B |
| Sectra AB | 69.94B |
| Getinge AB | 53.34B |
| Camurus AB | 41.80B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 21.77B |
| AddLife AB | 21.07B |